Epizyme
Cambridge
About Epizyme
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $834.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2019)
- Ticker: nasdaq:EPZM
- Website: epizyme.com
- Phone: 1(617)349-0707
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/epizyme-110939 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.